Mercaptopurine

CHEMBL1200751 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
152.2 g/mol
LogP
Phase
4

A chemotherapy drug used to treat acute lymphoblastic leukemia (ALL) and other blood cancers by interfering with DNA synthesis in rapidly dividing cells. It is usually taken daily by mouth as part of a maintenance treatment regimen.

Moleküler Ağırlık

152,1800 g/mol

LogP

0,00

TPSA

85,20 Ų

Lipinski RO5

Geçer

Terapötik Alanlar

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O.S=c1[nH]cnc2nc[nH]c12

InChI

InChI=1S/C5H4N4S.H2O/c10-5-3-4(7-1-6-3)8-2-9-5;/h1-2H,(H2,6,7,8,9,10);1H2

Molecular Formula

C5H4N4S

HBD / HBA

2 / 2

Döndürülebilir Bağlar

0

Ağır Atomlar

10

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A chemotherapy drug used to treat acute lymphoblastic leukemia (ALL) and other blood cancers by interfering with DNA synthesis in rapidly dividing cells. It is usually taken daily by mouth as part of a maintenance treatment regimen.

Yes, Mercaptopurine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200751. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 667490. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.